Brain Tumor
Ganciclovir pellets enhance effects of suicide gene therapy
Published in Gene Therapy Weekly, January 9th, 2003
Ganciclovir is a standard adjuvant to herpes simplex virus thymidine kinase (HSV-tk) gene therapy. Medical collaborators at Osaka University Medical School in Japan and the University of Sao Paulo Medical School in Brazil have reported that silicone-mixed ganciclovir pellets (GCV-pellet) extend survival in rodents bearing human gliosarcoma.
The researchers compared rodents treated with HSV-tk gene therapy and tumor-implanted GCV-pellet with other rodents treated with HSV-tk...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-01-09)
More Articles from Gene Therapy Weekly
- Transduction
Gene transfer efficiency of adeno-associated virus rests in cell type - Arthritis
Systemic gene therapy shows anti-inflammatory potential - Head and Neck Cancer
Adenoviral transfer of p27 gene decreases squamous cell carcinoma - Insulin Resistance
Tumor necrosis factor blockade may prevent metabolic meltdown - Neurodegeneration
Tumor suppressor protein capable of igniting neuron differentiation - AIDS Vaccine
Chiron extends collaboration to explore delivery of HIV vaccine - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
